![🔔 📢 NEW PUBLICATION: Empowering Effective Biomarker-Driven Precision Oncology: A Call to Action (Lawler et al., 2024)](https://cddf.org/wp-content/uploads/2024/07/Whitepaper-announcement-1080x675.jpg)
🔔 📢 NEW PUBLICATION: Empowering Effective Biomarker-Driven Precision Oncology: A Call to Action (Lawler et al., 2024)
The Cancer Drug Development Forum (CDDF) is delighted to announce that a white paper, “Empowering Effective Biomarker-Driven Precision Oncology: A Call to Action” has been published in European Journal of Cancer (Vol 209, September 2024). This paper has been developed...
![🔔 HMA/EMA Multi-stakeholder Workshop on Artificial Intelligence – 5 Nov 2024](https://cddf.org/wp-content/uploads/2024/07/Capture-3-1080x459.jpg)
🔔 HMA/EMA Multi-stakeholder Workshop on Artificial Intelligence – 5 Nov 2024
Check out the hybrid joint HMA/EMA multi-stakeholder workshop on Artificial Intelligence (AI) that will be held on 5 November 2024. The objectives of the workshop is to provide an update on the state-of-the-art of AI developments with keynote speakers: Update...
![[🔔 📢 Key Takeaways from the CDDF Webinar on “Cancer Medicines Forum: Advancing Cancer Treatment Optimization Across Europe”]](https://cddf.org/wp-content/uploads/2024/07/Capture-2-1080x675.jpg)
[🔔 📢 Key Takeaways from the CDDF Webinar on “Cancer Medicines Forum: Advancing Cancer Treatment Optimization Across Europe”]
The Cancer Drug Development Forum (CDDF) held a live webinar on Cancer Medicines Forum on 25 June 2024. In this webinar, Denis Lacombe (EORTC, BE) provided an interesting talk followed by a Q&A discussion moderated by Rosa Giuliani (CDDF, UK) and Daniel Goldstein...
![ACT EU: Materials from MSP AG Meeting – 4 July 2024](https://cddf.org/wp-content/uploads/2024/07/Capture-1.jpg)
ACT EU: Materials from MSP AG Meeting – 4 July 2024
Check out presentation slides from the MSP AG Meeting that took place on 4 July 2024 and stay up to date on topics of interest for clinical trials in the EU. Multi-stakeholder platform - European Union (europa.eu)
![ACT EU: Faster Access to Clinical Trial Information in Europe](https://cddf.org/wp-content/uploads/2024/06/Capture-1-1080x337.jpg)
ACT EU: Faster Access to Clinical Trial Information in Europe
The launch of a new version of the Clinical Trials Information System (CTIS) is giving earlier and more efficient access to clinical trial information in Europe. Revised transparency rules eliminate deferral mechanisms providing public access to approximately 4000...
![ACT EU: Two New Advice Pilots to Improve Clinical Trials in Europe](https://cddf.org/wp-content/uploads/2024/06/Capture-1080x341.jpg)
ACT EU: Two New Advice Pilots to Improve Clinical Trials in Europe
On 10 June 2024, the Accelerating Clinical Trials in the EU (ACT EU) initiative launched two advice pilots aimed at improving the quality of applications for clinical trials, the foundation for the development of safe and effective medicines in Europe. For more...